Lucky Pfizer CEO Bourla cashes out $5.6M worth of stock—perfectly legally—as COVID-19 vaccine data lift market | Fierce Pharma
From Pfizer to Moderna: who's making billions from Covid-19 vaccines? | Pharmaceuticals industry | The Guardian
Albert Bourla - Chief Executive Officer - Pfizer | LinkedIn
Pfizer CEO Albert Bourla on developing a COVID vaccine in less than a year | Fortune
Albert Bourla: Net Worth, Biography, Age, Career, Salary & More - MTM
10 US marijuana CEOs get million-dollar pay in 2020 as disclosure practices questioned
The CEO of Pfizer on Developing a Vaccine in Record Time
Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see more | S&P Global Market Intelligence
Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see more | S&P Global Market Intelligence
Chief executives of mRNA vaccine groups earned $100mn in pandemic pay | Financial Times
Ex-Pfizer CEO Ian Read sees 2018 pay slashed by a third as incentive package plummets | Fierce Pharma
Pfizer CEO: What's next for vaccines, tech and the pandemic | World Economic Forum
Pfizer CEO gets 61% pay raise—to $27.9 million—as drug prices continue to climb | Ars Technica
Meet Married BioNTech Billionaires Who Helped Create Pfizer Vaccine
Dr. Albert Bourla | Pfizer
Albert Bourla won't testify in front of the European Parliament
Pfizer chief sold $5.6m of shares as investors hailed vaccine | Financial Times
Pfizer CEO Albert Bourla sold US$5.6 million stock on day of vaccine news
Pfizer CEO Read to Step Aside at Year's End - WSJ
Albert Bourla - Wikipedia
Chart: Pfizer Revenue Boosted by Covid-19 Drugs | Statista
Coronavirus vaccine: Pfizer CEO sold $5.6 million of stock as company announced positive data
